GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Book Value per Share History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Book NAV/Share(Rs) | 134.77 | 116.06 | 105.47 | 102.89 | 157.19 |
What is the latest Book Value per Share ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Book Value per Share |
|---|---|
| Mar2026 | 134.77 |
| Mar2025 | 116.06 |
| Mar2024 | 105.47 |
| Mar2023 | 102.89 |
| Mar2022 | 157.19 |
How is Book Value per Share of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Book Value per Share | % Change | |
|---|---|---|---|
| Mar2026 | 134.77 | 16.12 | |
| Mar2025 | 116.06 | 10.04 | |
| Mar2024 | 105.47 | 2.51 | |
| Mar2023 | 102.89 | -34.54 | |
| Mar2022 | 157.19 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Book Value per Share ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹51,396.8 Cr | 13.9% | 21.1% | 11.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 13.9% |
21.1% |
11.4% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses